274 related articles for article (PubMed ID: 30104364)
21. Thrombocytopenia in c-mpl-deficient mice.
Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW
Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287
[TBL] [Abstract][Full Text] [Related]
22. Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34(+) cells with stem cell factor and promegapoietin.
Kratz-Albers K; Scheding S; Möhle R; Bühring HJ; Baum CM; Mc Kearn JP; Büchner T; Kanz L; Brugger W
Exp Hematol; 2000 Mar; 28(3):335-46. PubMed ID: 10720698
[TBL] [Abstract][Full Text] [Related]
23. Deficient in vitro megakaryocytopoiesis and decreased in vivo platelet turnover in children and young adults with chronic thrombocytopenia.
Parker RI; Siegel RS; Ratajczak MZ; Gewirtz AM
J Pediatr Hematol Oncol; 1998; 20(3):196-201. PubMed ID: 9628429
[TBL] [Abstract][Full Text] [Related]
24. Flt3/Flk-2-ligand in synergy with thrombopoietin delays megakaryocyte development and increases the numbers of megakaryocyte progenitor cells in serum-free cultures initiated with CD34+ cells.
Sigurjónsson OE; Gudmundsson KO; Haraldsdóttir V; Rafnar T; Gudmundsson S
J Hematother Stem Cell Res; 2002 Apr; 11(2):389-400. PubMed ID: 11983110
[TBL] [Abstract][Full Text] [Related]
25. Thrombopoietin signalling in physiology and disease.
Fishley B; Alexander WS
Growth Factors; 2004 Sep; 22(3):151-5. PubMed ID: 15518238
[TBL] [Abstract][Full Text] [Related]
26. The secret life of a megakaryocyte: emerging roles in bone marrow homeostasis control.
Malara A; Abbonante V; Di Buduo CA; Tozzi L; Currao M; Balduini A
Cell Mol Life Sci; 2015 Apr; 72(8):1517-36. PubMed ID: 25572292
[TBL] [Abstract][Full Text] [Related]
27. Megakaryocyte development and platelet production.
Deutsch VR; Tomer A
Br J Haematol; 2006 Sep; 134(5):453-66. PubMed ID: 16856888
[TBL] [Abstract][Full Text] [Related]
28. Thrombopoietin, but not cytokines binding to gp130 protein-coupled receptors, activates MAPKp42/44, AKT, and STAT proteins in normal human CD34+ cells, megakaryocytes, and platelets.
Majka M; Ratajczak J; Villaire G; Kubiczek K; Marquez LA; Janowska-Wieczorek A; Ratajczak MZ
Exp Hematol; 2002 Jul; 30(7):751-60. PubMed ID: 12135673
[TBL] [Abstract][Full Text] [Related]
29. Contributions of TRAIL-mediated megakaryocyte apoptosis to impaired megakaryocyte and platelet production in immune thrombocytopenia.
Yang L; Wang L; Zhao CH; Zhu XJ; Hou Y; Jun P; Hou M
Blood; 2010 Nov; 116(20):4307-16. PubMed ID: 20671119
[TBL] [Abstract][Full Text] [Related]
30. H2S protects against fatal myelosuppression by promoting the generation of megakaryocytes/platelets.
Liu HD; Zhang AJ; Xu JJ; Chen Y; Zhu YC
J Hematol Oncol; 2016 Feb; 9():13. PubMed ID: 26912146
[TBL] [Abstract][Full Text] [Related]
31. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
[TBL] [Abstract][Full Text] [Related]
32. Thrombopoietin Metabolically Primes Hematopoietic Stem Cells to Megakaryocyte-Lineage Differentiation.
Nakamura-Ishizu A; Matsumura T; Stumpf PS; Umemoto T; Takizawa H; Takihara Y; O'Neil A; Majeed ABBA; MacArthur BD; Suda T
Cell Rep; 2018 Nov; 25(7):1772-1785.e6. PubMed ID: 30428347
[TBL] [Abstract][Full Text] [Related]
33. Thrombocytopenia in MDS: epidemiology, mechanisms, clinical consequences and novel therapeutic strategies.
Li W; Morrone K; Kambhampati S; Will B; Steidl U; Verma A
Leukemia; 2016 Mar; 30(3):536-44. PubMed ID: 26500138
[TBL] [Abstract][Full Text] [Related]
34. Thrombopoietin is essential for the maintenance of normal hematopoiesis in humans: development of aplastic anemia in patients with congenital amegakaryocytic thrombocytopenia.
Ballmaier M; Germeshausen M; Krukemeier S; Welte K
Ann N Y Acad Sci; 2003 May; 996():17-25. PubMed ID: 12799278
[TBL] [Abstract][Full Text] [Related]
35. Effect of thrombopoietin receptor agonists on the apoptotic profile of platelets in patients with chronic immune thrombocytopenia.
Mitchell WB; Pinheiro MP; Boulad N; Kaplan D; Edison MN; Psaila B; Karpoff M; White MJ; Josefsson EC; Kile BT; Bussel JB
Am J Hematol; 2014 Dec; 89(12):E228-34. PubMed ID: 25132654
[TBL] [Abstract][Full Text] [Related]
36. Two patterns of thrombopoietin signaling suggest no coupling between platelet production and thrombopoietin reactivity in thrombocytopenia-absent radii syndrome.
Fiedler J; Strauss G; Wannack M; Schwiebert S; Seidel K; Henning K; Klopocki E; Schmugge M; Gaedicke G; Schulze H
Haematologica; 2012 Jan; 97(1):73-81. PubMed ID: 21933853
[TBL] [Abstract][Full Text] [Related]
37. Thrombopoietin has a primary role in the regulation of platelet production in preterm babies.
Watts TL; Murray NA; Roberts IA
Pediatr Res; 1999 Jul; 46(1):28-32. PubMed ID: 10400130
[TBL] [Abstract][Full Text] [Related]
38. Thrombopoietin is synergistic with other cytokines for expansion of cord blood progenitor cells.
Won JH; Cho SD; Park SK; Lee GT; Baick SH; Suh WS; Hong DS; Park HS
J Hematother Stem Cell Res; 2000 Aug; 9(4):465-73. PubMed ID: 10982244
[TBL] [Abstract][Full Text] [Related]
39. Physiologic role of TPO in thrombopoiesis.
Miyazaki H
Stem Cells; 1996; 14 Suppl 1():133-8. PubMed ID: 11012213
[TBL] [Abstract][Full Text] [Related]
40. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
